| HS Code | 584682 |
| Chemical Name | Composite Calcium Hypochlorite |
| Cas Number | 7778-54-3 |
| Molecular Formula | Ca(ClO)2 |
| Appearance | White or off-white granular powder |
| Solubility | Freely soluble in water |
| Available Chlorine Content | 60.0% – 70.0% w/w |
| Assay Calcium Hypochlorite | 65.0% – 75.0% w/w |
| Ph 1 W V Aqueous Solution | 10.5 – 12.5 |
As an accredited Composite Calcium Hypochlorite Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packaged in sealed 25 kg drums, double-lined with desiccant, labelled for veterinary grade composite calcium hypochlorite powder. |
| Container Loading (20′ FCL) | 20′ FCL loaded with veterinary-grade Composite Calcium Hypochlorite Powder API, securely packed on pallets in moisture-proof containers for safe transport. |
| Shipping | Ship as UN 2880 Calcium hypochlorite mixture, dry — Class 5.1 oxidizing solid. This veterinary-grade API requires DG-compliant packaging: approved, sealed drums/IBCs with polyethylene liners. Keep away from combustibles, acids, moisture, and foodstuffs. Label as oxidizer, declare on shipping documents, and follow IMDG, IATA, and road transport regulations. |
| Storage | Store in a cool, dry, well-ventilated area away from direct sunlight, heat, and moisture. Keep container tightly closed when not in use. Protect from contamination, acids, organic materials, and reducing agents. Use original packaging; avoid contact with incompatible substances. Ensure secure, clearly labeled storage to maintain stability and veterinary-grade quality throughout shelf life. |
| Shelf Life | Shelf life: 24 months when stored in original sealed container, in a cool, dry place away from sunlight. |
Continuous metering of composite calcium hypochlorite stock solution into poultry and swine drinking water systems is used for residual maintenance rather than primary sterilisation. The target free residual chlorine at the furthest drinker is maintained between 0.2 mg/L and 0.5 mg/L, with a contact time of 30 minutes before first animal exposure; this residual range follows WHO Guidelines for Drinking-water Quality guidance for point-of-use chlorination. A single 1.7 g tablet containing 60 wt% available chlorine, introduced into 1,000 L of water, produces approximately 1.0 mg/L available chlorine for stock preparation. The downstream production line for this application blends the active powder with 20–30 wt% sodium sulfate as a desiccant and dissolution aid, plus 5–10 wt% sodium carbonate as pH buffer, before direct compression on a 16-station B-tooling rotary press at 8–12 kN precompression and 20–30 kN main compression. Finished product types are single-dose tablets, foil-wrapped powder sachets, and pre-weighed granular pouches for farm header tanks. In cold weather below 10 °C, dissolution slows and visible fines have been observed in low-shear tanks; a recirculation loop or venturi eductor is required to maintain complete dissolution. The material is not formulated into gelatin capsules or aqueous injectable matrices because the oxidant degrades gelatin and is incompatible with parenteral pH and tissue tolerability requirements.
In continuous metering installations, the stock solution is held in an HDPE tank with a sealed lid and dilute solution is injected into the water line through a diaphragm metering pump with a degassing head. pH is controlled between 6.5 and 7.5 to favour hypochlorous acid over hypochlorite ion; acid injection upstream must be avoided because pH below 4.0 liberates chlorine gas. Monitoring uses DPD colorimetric or amperometric free-chlorine measurement at the drinker line, with a minimum ORP setpoint of 650 mV for systems that use continuous redox feedback. NSF/ANSI 60 certification applies where the concentrated chemical is used for drinking water in the United States; EU formulators place the application under Biocidal Products Regulation product-type 5 for drinking water disinfectants. Batch-to-batch variance in tablet hardness above 80 N has been associated with capping in field repacking, which is controlled by limiting compression force and maintaining relative humidity below 35% during storage.
In dairy parlour and milk-room sanitation, calcium hypochlorite solutions are used as terminal sanitising rinses at concentrations that do not require a potable-water rinse under FDA 21 CFR 178.1010(b). The working solution is prepared at 100–200 mg/L available chlorine, typically by dissolving one 1.7 g tablet containing 60 wt% available chlorine in 10 L water; this yields approximately 100 mg/L available chlorine and is circulated through 316L stainless steel clean-in-place lines for 10–15 minutes at 15–25 °C. Bactericidal performance under EN 1656:2019 is verified as a ≥5 log reduction of Enterococcus hirae ATCC 10541 in 30 minutes under clean conditions, but organic soil reduces available chlorine rapidly; alkaline detergent cleaning and an intermediate potable-water rinse are therefore mandatory before terminal sanitisation. The production process for this segment involves dry blending the composite powder with 0.2–0.5 wt% silica anti-caking agent, filling low-permeation polyethylene sachets, and nitrogen-flush sealing to prevent moisture absorption. Terminal product types include water-soluble sachets, bulk powder pails, and point-of-use liquid concentrate refills.
Operational boundaries include pitting corrosion of 316L stainless steel when chloride load exceeds 600 mg/L at pH 6.0 for repeated cycles; circuits should be drained or blown clear where dwell times exceed 30 minutes. Because hypochlorite oxidises milk proteins and fats, recovery of the solution for reuse is not recommended once turbidity exceeds 100 NTU. The solution must not be blended with quaternary ammonium compounds, amine-based detergents, or citric acid-based descalers in the same CIP sequence; these combinations generate chloramines or gaseous chlorine and reduce measurable free chlorine.
Drained pond bottoms on shrimp and finfish farms are treated with calcium hypochlorite granules to oxidize organic matter and reduce pathogen carry-over between cycles. Equipment soak concentrations for nets, harvest bins, and transfer tanks are prepared at 200–500 mg/L available chlorine; pond bottom oxidation rates cited in extension guidance range from 30 g/m² to 50 g/m² of drained pond bottom, but peer-reviewed dose-response data for specific soil organic carbon loads remains limited. The granules are distributed with a belt-type fertilizer spreader or hand-broadcast after sludge removal, followed by 7–14 days drying and reflooding with screened intake water. Compliance for veterinary hygiene use falls under EU BPR product-type 3, with bactericidal activity demonstrated against Aeromonas salmonicida and Vibrio parahaemolyticus using EN 1656:2019 suspension tests adapted for aquatic pathogens. Downstream production at the formulator level consists of roll compaction at 30–50 kN roll force, sieving to 0.8–2.0 mm particle size, and packaging in 5 kg or 25 kg UN-approved fibre drums. Terminal product types are broadcast granules, soluble powder pails, and pre-measured water-soluble bags for equipment disinfection. Direct combination with formalin, ammonium salts, or sodium thiosulfate must be excluded because these reactants consume free chlorine or generate chlorinated by-products before contact time is achieved.
Because pond water alkalinity and dissolved organic carbon reduce available chlorine, field verification uses DPD titration at 30 minutes after application, with the objective of holding 0.5–1.0 mg/L free residual in equipment soak water. For pond bottom treatment, liming may precede hypochlorite application to raise pH to 7.0–8.0, which reduces acid-gas release while retaining oxidising activity. Equipment in contact with hypochlorite solutions is fabricated from HDPE or fibreglass; mild steel and aluminium are excluded due to corrosion and metal-catalysed decomposition.
The dosage matrix below consolidates the formulation addition ratios, contact times, and standards for the above application zones and the biosecurity and hatchery scenarios that follow.
| Application zone | Target available chlorine | Contact time | pH operating range | Recognition/standard | Terminal format |
|---|---|---|---|---|---|
| Poultry/swine drinking water residual | 0.2–0.5 mg/L at drinker | 30 min | 6.5–7.5 | WHO GDWQ; NSF/ANSI 60; EU BPR PT 5 | Tablets, powder sachets, granules |
| Dairy milk-contact sanitising circuit | 100–200 mg/L | 10–15 min | 6.0–8.0 | FDA 21 CFR 178.1010(b); EN 1656:2019 | Water-soluble sachets, powder pails, liquid concentrate refills |
| Aquaculture equipment soak | 200–500 mg/L | 10–30 min | 6.5–8.0 | EN 1656:2019; EU BPR PT 3 | Broadcast granules, soluble powder pails, water-soluble bags |
| Boot dip biosecurity | 1,500–2,000 mg/L | 4–6 h replenishment interval | 6.5–8.0 | EN 1656:2019; EN 14675:2015 | Pre-weighed pouches, pails, tablets |
| Vehicle wheel bath | 3,000–5,000 mg/L | 4–6 h replenishment interval | 6.5–8.0 | EN 1656:2019; EN 14675:2015 | Granules, bulk pails, tablets |
| Hatchery tray and egg-room sanitation | 100–200 mg/L | 10–30 min | 6.5–7.5 | EN 1656:2019 | Barrier-packed tablets, powder sachets, water-soluble film pouches |
Swine and poultry high-biosecurity sites use granulated calcium hypochlorite in footbaths and vehicle wheel dips where transient organic soiling would otherwise neutralise free chlorine. The operating target is 1,500–2,000 mg/L available chlorine for boot dips and 3,000–5,000 mg/L for wheel baths; a 20 L boot dip therefore requires 46–62 g of a 65 wt% powder to achieve the boot-dip target. Solutions are prepared in high-density polyethylene trays, not galvanised steel, because cupric and ferric ions accelerate hypochlorite decomposition. Production of the granular product used in this application involves blending the composite powder with 2–5 wt% sodium carbonate as a pH buffer and 0.5 wt% sodium silicate as a drying aid, followed by roll compaction to produce free-flowing granules with 0.8–1.6 mm particle size. Terminal products include pre-weighed water-soluble pouches for footbaths, 10 kg pails for vehicle disinfection, and tablet formats that simplify pit recharge. The main operational boundary is organic load: visible soil reduces free chlorine below virucidal thresholds within 4–6 hours, so recharging or replacement is required at that interval. Compliance is evaluated under EU BPR product-type 3 and, for virucidal claims, EN 14675:2015 is the recognised quantitative suspension test; sodium thiosulfate neutralisation is used in efficacy testing to prevent overestimation of contact time.
Hatchery trays, chick boxes, and egg-room wall panels are soaked in calcium hypochlorite solutions at 100–200 mg/L available chlorine for 10–30 minutes, followed by potable-water rinse when surface contact with eggs or chicks is expected. If rinse water is omitted, residual chlorine on porous animal-contact surfaces is verified to be below 0.5 mg/L by DPD colorimetric measurement before reuse. The downstream product is a soluble powder or non-effervescent tablet because acid donors are omitted to avoid gaseous chlorine release. Production includes blending with 20–30 wt% sodium sulfate as a desiccant and dissolution aid, direct compression into 3.4 g tablets, and foil barrier packaging with desiccant sachets. Finished product types include barrier-packed tablets, powder sachets, and water-soluble film pouches. Incompatibility with aluminium hatchery trays is noted; only plastic or fibreglass trays should be soaked because hypochlorite induces pitting on aluminium under alkaline pH above 8.5.
The following compliance matrix consolidates the standard designations referenced across the downstream scenarios.
| Standard/code | Scope | Application relevance |
|---|---|---|
| EU BPR Annex V PT 3 | Veterinary hygiene disinfectants | Boot dips, vehicle disinfection, aquaculture equipment, hatchery surfaces |
| EU BPR Annex V PT 5 | Drinking water disinfectants for animals | Poultry and swine drinking water residual maintenance |
| EN 1656:2019 | Bactericidal activity in veterinary field | Quantitative suspension test for Gram-positive and Gram-negative target organisms |
| EN 14675:2015 | Virucidal activity in veterinary area | Virucidal claims for farm biosecurity footbaths and wheel baths |
| FDA 21 CFR 178.1010(b) | Sanitising solutions for food-contact surfaces | Dairy milk-contact terminal sanitising rinse without potable-water post-rinse |
| NSF/ANSI 60 | Drinking water treatment chemicals health effects | US drinking water chemical suitability for animal water systems |
| WHO GDWQ | Point-of-use chlorination guidance | Free residual chlorine and contact time targets for drinking water |
| UN 2880 | Calcium hypochlorite hydrated transport classification | Class 5.1, Packing Group II oxidiser packaging and logistics |
Downstream solid dosage manufacturing of calcium hypochlorite-based veterinary water-disinfection products is constrained by humidity, metal contact, and oxidizer incompatibility. Formulations for compressed tablets typically contain 50–70 wt% calcium hypochlorite, 20–30 wt% sodium sulfate, 5–10 wt% sodium carbonate, and 0.1–0.5 wt% magnesium stearate as die lubricant; organic binders such as povidone, microcrystalline cellulose, or starch are excluded because of exothermic oxidative degradation. Direct compression is performed on stainless steel punches and dies at relative humidity ≤35% and room temperature 18–25 °C. Observed field failures include capping at tablet hardness exceeding 80 N and die wall filming when magnesium stearate is below 0.1 wt%. Compliance for the chemical substance includes UN transport classification as UN 2880, Class 5.1, Packing Group II, and REACH registration obligations under the biocidal active substance review; US distributors additionally verify NSF/ANSI 60 certification for drinking-water chemical suitability. Terminal product types are compressed tablets, bulk granules, and dry premix intermediates for re-packagers; capsules and injectable solutions are excluded because the oxidant degrades gelatin shells and is incompatible with aqueous parenteral matrices.
Competitive Composite Calcium Hypochlorite Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Composite calcium hypochlorite powder, identified in commercial documentation as a veterinary-grade active ingredient for tablets, injections, capsules, powders, granules, premix, and solutions, is a solid oxidizing matrix in which calcium hypochlorite, Ca(OCl)₂, is co-processed with calcium carbonate, calcium chloride, and controlled free moisture. The available chlorine content is typically 65–70% w/w by iodometric titration following AWWA B300. The term “API” in this context denotes a controlled-specification chemical intermediate for downstream dilution or solid-dose disinfection; it does not establish a harmonized veterinary pharmacopoeial monograph. No safe systemic exposure threshold has been published for calcium hypochlorite, and the material is not used as a parenteral or oral drug. Its established application is environmental and water sanitation, where the dose, contact time, and free available chlorine residual can be measured.
Model identification is manufacturer-specific. Commercial lots may carry a plant code such as CCAP-VG65 or an internal production reference; the model alone is insufficient to confirm formulation fitness because the stabilizer-to-hypochlorite ratio, residual moisture, and particle-size distribution can vary between production campaigns. A purchase specification must include a certificate of analysis that states available chlorine, moisture, particle-size distribution, insoluble matter, and residual oxidizable impurities.
The values in Table 1 are representative technical-data-sheet limits for hydrated calcium hypochlorite disinfectant grades; they are not a harmonized veterinary monograph and must be confirmed against each lot certificate. Parameters may differ for dry grades with reduced moisture. Batch-to-batch variance is most pronounced in particle-size distribution and free moisture because commercial synthesis and co-stabilization are controlled by continuous high-shear blending and plate cooling. In production-scale handling, undried fine fractions may adhere to weigh hoppers and screw conveyors, causing feed interruptions. Loss-in-weight feeders with polyethylene-lined contact surfaces are specified to manage this flow behavior. Published run-time data for this specific composite is limited; roller-compaction or dry-granulation trials are recommended before large-quantity solid-dose manufacture.
| Parameter | Method or designated standard | Typical limit or range |
|---|---|---|
| Available chlorine, as Cl₂ | AWWA B300 iodometric titration | 65.0–70.0% w/w |
| Moisture, hydrated grade | AWWA B300 gravimetric moisture | 5.5–10.0% w/w |
| Bulk density, poured | ASTM D1895 Method B | 0.80–1.10 g/cm³ |
| Particle size, retained on 2.00 mm | ASTM E11 sieve | ≤5.0% |
| Particle size, passing 150 µm | ASTM E11 sieve | ≤25.0% |
| pH of 1% solution at 25°C | ASTM D1293 Method B | 10.0–11.5 |
| Matter insoluble in water | AWWA B300 gravimetric | ≤2.0% w/w |
Residual calcium chlorate content should be requested on the certificate of analysis because elevated chlorate levels are relevant for dairy and poultry water quality; no harmonized limit for veterinary-grade calcium hypochlorite composite has been established. Acceptance sampling for incoming containers may follow ISO 2859-1 with an AQL of 1.0 for available chlorine and moisture; more stringent sampling is required if containers show evidence of moisture ingress or if the shipment has been exposed to temperatures above 30°C.
Although the commercial designation lists tablets, injections, capsules, powders, granules, premix, and solutions as possible formulation classes, the intrinsic chemistry of the hypochlorite ion restricts the product to disinfectant dosage forms. A 1% available chlorine solution has an alkaline pH of approximately 10.0–11.5; the chlorine equilibrium shifts to hypochlorous acid only below pH 7.5, and hypochlorous acid is a nonspecific oxidant for thiols, methionine residues, and membrane lipids. No pharmacokinetic or toxicological data support parenteral or oral-capsule administration in food-producing species, and the USP–NF does not provide a monograph for calcium hypochlorite as a veterinary drug. The word “tablet” is therefore interpreted as a disinfectant tablet for water or surface treatment, not an oral solid dosage form. Formulation as an injection would be incompatible with the oxidizing potential and alkaline pH; any such development would require a separate safety and residue package under the relevant veterinary drug regulations.
Use as a feed premix is not supported. Feed matrices contain proteins, fats, and reducing sugars that rapidly consume free chlorine; an oral premix claim would require residue and target-animal safety data under 21 CFR 558 or equivalent, and no such sanctioned claim exists for calcium hypochlorite in major veterinary jurisdictions. The product is handled as a premises and water biocide, not as a nutritional or systemic medicated premix.
Practical dilution of a 65% available chlorine composite to a 1.0% available chlorine stock solution requires 1.54 kg of product per 100 L of clean water. The material is added to water, not the reverse, because the hydration reaction is exothermic. Low-shear mixing tanks should be constructed of high-density polyethylene, polypropylene, or fibreglass-reinforced polyester; carbon steel and galvanized components corrode rapidly at the alkaline pH. The resulting solution is standardized iodometrically before use because available chlorine declines with temperature, light, and organic contamination. Stock solutions prepared at 1.0% available chlorine and stored at 20–25°C exhibit measurable strength loss within 24–48 h unless kept in closed, light-shielded vessels. Production sites should batch only what is consumed within one shift or implement iodometric restandardization before the next dosing cycle.
Drinking-water sanitation in poultry and swine housing commonly uses proportional dosing pumps calibrated to maintain 1–5 mg/L free available chlorine at the drinker line. The required dose varies with water pH, ammonia concentration, and biofilm demand. At pH 6.5–7.5 hypochlorous acid predominates; at pH 8.5 the equilibrium shifts toward hypochlorite ion, which has substantially lower bactericidal activity. Residual chlorine must be measured at the end of the drinker line using a DPD or amperometric method, not at the stock tank, because distribution lines exert a strong chlorine demand.
For nonporous surface disinfection, a solution containing 500–1,000 mg/L available chlorine and a contact time of 10 min is typical for pre-cleaned concrete, stainless steel, and plastic surfaces. Organic soiling from manure, milk, or blood consumes free chlorine; pre-cleaning with an alkaline detergent is required. Heavily soiled pens may require 2,000 mg/L, but corrosion of galvanized feeders, gate hardware, and electrical fittings increases with concentration and contact time. Disinfection efficacy claims should be validated by AOAC 960.09 or an equivalent local test method for the specific target organism and surface.
Solid-dose disinfectant tablets are produced by dry granulation or roller compaction rather than wet granulation because adding water initiates decomposition and reduces available chlorine. Rotary tablet presses used for this product should be equipped with 316L stainless steel contact parts, dust extraction rated for oxidizer service, and environmental controls maintaining relative humidity below 40%. Lubricants and binders must be selected for oxidative compatibility; magnesium stearate and conventional fatty acid lubricants are generally avoided with strong oxidizers. Published run-time data for a specific composite grade is limited; feasibility trials should quantify available chlorine loss after 48 h open storage and granule friability before committing to full production.
In contrast to liquid sodium hypochlorite, which is supplied at 10–15% available chlorine and degrades rapidly above 30°C, the composite form reduces transportation mass by approximately 4–6-fold per kilogram of chlorine equivalent. It also avoids the large water volume and sodium loading of liquid bleach but introduces oxidizer-dust hazards and alkaline pH. Compared with sodium dichloroisocyanurate, the calcium hypochlorite composite produces higher pH and may form calcium carbonate scale in hard water; compared with trichloroisocyanuric acid, it is less acidic but leaves more inorganic residue. Table 2 summarizes these differences.
| Chlorine carrier | Typical available chlorine (% w/w) | Common physical form | Primary handling constraint |
|---|---|---|---|
| Composite calcium hypochlorite | 65–70 | solid powder/granule | oxidizer, exothermic on wetting, alkaline pH |
| Sodium hypochlorite solution | 10–15 | liquid | rapid degradation above 30°C, liquid bulk |
| Sodium dichloroisocyanurate | 55–60 | tablet/granule | cyanurate residue, lower pH |
| Trichloroisocyanuric acid | 90 | tablet/granule | acidic corrosion, pH near 3 |
| Chloramine-T | 24–25 | powder | slower release, lower oxidation potential |
The product is an oxidizing solid under transport regulations. Hydrated grades may be consigned as UN 2880; dry grades may be consigned as UN 1748, depending on moisture and available chlorine. The shipping classification must be verified with the safety data sheet and the package label. Storage should be maintained below 30°C in a dry, ventilated area. If relative humidity exceeds 60%, partially opened containers absorb moisture, and the wetted material releases chlorine gas and heat. Containers must be reclosed immediately after dispensing, and packages should use vented closures to prevent pressure accumulation from slow decomposition.
Chemical incompatibilities govern warehouse and mixing operations. Contact with acids generates rapid hypochlorous acid formation and can cause violent release of chlorine; contact with ammonia, amines, and urine-tainted litter generates chloramines; contact with hydrocarbons, glycols, or combustible packaging can initiate self-sustaining oxidation. These hazards are addressed under hazard communication and storage standards such as OSHA 29 CFR 1910.1200 and NFPA 400, where applicable. Spray equipment and dilution tanks require corrosion-resistant elastomer seals selected from the supplier’s compatibility chart; natural rubber and neoprene degrade rapidly in concentrated calcium hypochlorite service. Published data for this specific composite is limited; each facility should perform a site-specific risk assessment.
In hard water, repeated use precipitates calcium carbonate and can scale drinker lines and proportioner parts. Periodic acid descaling with citric acid or acetic acid may be required, followed by thorough rinsing before chlorine solution is reintroduced. Acid must never come into contact with calcium hypochlorite powder or concentrated stock solution. This operational boundary is critical because incidental mixing of acid descaling chemicals with calcium hypochlorite has produced rapid chlorine release at farm scale; the resulting vapour is a severe respiratory hazard to livestock and personnel.